首页> 外文期刊>Journal of Gynecologic Oncology >Role of high risk-human papilloma virus test in the follow-up of patients who underwent conization of the cervix for cervical intraepithelial neoplasia
【24h】

Role of high risk-human papilloma virus test in the follow-up of patients who underwent conization of the cervix for cervical intraepithelial neoplasia

机译:高危型人乳头瘤病毒测试在宫颈锥切术治疗宫颈上皮内瘤变患者中的作用

获取原文
           

摘要

Objective To examine whether the presence of high risk-human papilloma virus (HR-HPV) after conization of the cervix was a risk factor for persistence or recurrence of cervical intraepithelial neoplasia (CIN) and whether HR-HPV test could be a guideline for post-therapy surveillance. Methods The study retrospectively analyzed data from 243 patients who underwent LLETZ or CKC of the cervix due to CIN. Results A positive HR-HPV test result which was performed between 3 and 6 months after procedure was a risk factor for persistent or recurrent cytological (p Conclusion HR-HPV positive patients between 3 and 6 months after procedure should undergo frequent and meticulous post-therapy surveillance, while HR-HPV negative patients do not require such high-level surveillance and could undergo routine surveillance.
机译:目的探讨宫颈锥切术后是否存在高危人类乳头瘤病毒(HR-HPV)是宫颈上皮内瘤变(CIN)持续或复发的危险因素,以及HR-HPV检测是否可以作为宫颈癌术后的指南治疗监视。方法这项研究回顾性分析了243例因CIN行宫颈LLETZ或CKC的患者的数据。结果术后3至6个月HR-HPV检测结果阳性是细胞持续或复发的危险因素(p结论术后3至6个月HR-HPV阳性患者应进行频繁且细致的治疗。监测,而HR-HPV阴性患者则不需要如此高水平的监测,可以接受常规监测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号